Treatment with lonafarnib extends survival in children with Progeria: Study
A new study published in JAMA reports that an farnesyltransferase inhibitor (FTI), helps extend survival in children with HGPS
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.